STARS Common Strategy

The STARS Common Strategy highlights the achievements of STARS projects and focusses on the opportunities to strengthen regulatory science and knowledge. Based on the various project activities, the current status was described and 21 recommendations were developed together with key stakeholders. This document is the STARS road map for the implementation of support activities and training programmes, with the goal to strengthen regulatory sciences and improve successful outcomes from innovative and academic-driven clinical research projects.

Strategic recommendations from the STARS project to foster academic drug development

Publication in Nature Reviews Drug Discovery 22, 251-252 (2023)

https://www.nature.com/articles/d41573-023-00021-z

Translating academic drug discovery into clinical development: a survey of the awareness of regulatory support and requirements among stakeholders in Europe

Open access article: Clinical Pharmacology & Therapeutics Vol 113, Issue 2, February 2023, Pages 349-359

https://ascpt.onlinelibrary.wiley.com/doi/full/10.1002/cpt.2789

Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap

Publication in Drug Discovery Today, Volume 26, Issue 2, February 2021, Pages 283-288

https://www.sciencedirect.com/science/article/pii/S1359644620304347